{
    "organizations": [],
    "uuid": "708b054a0a54973d8c039b56ae4f8499088f61bb",
    "author": "",
    "url": "https://www.reuters.com/article/brief-esperion-posts-qtrly-loss-per-shar/brief-esperion-posts-qtrly-loss-per-share-1-73-idUSASC09YYU",
    "ord_in_thread": 0,
    "title": "BRIEF-Esperion Posts Qtrly Loss Per Share $1.73",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 2, 2018 / 11:50 AM / Updated 10 minutes ago BRIEF-Esperion Posts Qtrly Loss Per Share $1.73 Reuters Staff\nMay 2 (Reuters) - Esperion Therapeutics Inc:\n* ESPERION PROVIDES BEMPEDOIC ACID FRANCHISE DEVELOPMENT PROGRAM UPDATES; REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS\n* ESPERION THERAPEUTICS INC - EXPECTS FULL-YEAR 2018 NET CASH USED IN OPERATING ACTIVITIES TO BE APPROXIMATELY $135 TO $145 MILLION\n* ESPERION THERAPEUTICS - ESTIMATES THAT CURRENT CASH RESOURCES ARE SUFFICIENT TO FUND OPERATIONS THROUGH Q1 OF 2020\n* ESPERION THERAPEUTICS INC - EXPECTS CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES TO BE APPROXIMATELY $130 TO $140 MILLION AT DECEMBER 31, 2018\n* ESPERION THERAPEUTICS INC QTRLY LOSS PER SHARE $1.73 Source text for Eikon: Further company coverage:",
    "published": "2018-05-02T14:49:00.000+03:00",
    "crawled": "2018-05-02T15:10:44.021+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "updated",
        "minute",
        "ago",
        "post",
        "qtrly",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "may",
        "reuters",
        "esperion",
        "therapeutic",
        "inc",
        "esperion",
        "provides",
        "bempedoic",
        "acid",
        "franchise",
        "development",
        "program",
        "update",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "esperion",
        "therapeutic",
        "inc",
        "expects",
        "net",
        "cash",
        "used",
        "operating",
        "activity",
        "approximately",
        "million",
        "esperion",
        "therapeutic",
        "estimate",
        "current",
        "cash",
        "resource",
        "sufficient",
        "fund",
        "operation",
        "q1",
        "esperion",
        "therapeutic",
        "inc",
        "expects",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "security",
        "approximately",
        "million",
        "december",
        "esperion",
        "therapeutic",
        "inc",
        "qtrly",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}